Post-approval studies (Phase 4)Study completedNCT00137397
What this trial is testing
Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder
Who this might be right for
Urinary Incontinence
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 80